| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.03B | -11.3% |
| Cost of Revenue | $4.72B | -8.8% |
| Gross Profit | $1.31B | -19.2% |
| R&D Expense | $108.0M | -8.5% |
| SG&A Expense | $1.29B | +81.7% |
| Interest Expense | $208.0M | +27.6% |
| Pre-tax Income | -$318.0M | -142.9% |
| Income Tax | -$81.0M | -149.7% |
| Net Income | -$238.0M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.20B | +9.2% |
| Accounts Receivable | $509.0M | +0.0% |
| Inventory | $1.35B | -3.7% |
| Current Assets | $3.83B | +19.3% |
| Total Assets | $8.25B | +8.0% |
| Current Liabilities | $2.49B | +31.5% |
| Long-term Debt | $3.99B | +11.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $556.0M | -26.3% |
| Capital Expenditures | $370.0M | +20.5% |
| Investing Cash Flow | -$229.0M | +19.4% |
| Financing Cash Flow | $172.0M | +125.1% |
| Free Cash Flow | $186.0M | -58.4% |
| -141.2% |
| EPS (Basic) | -$1.60 | -143.0% |
| EPS (Diluted) | -$1.60 | -143.8% |
| Total Liabilities |
| $7.51B |
| +15.0% |
| Stockholders' Equity | $737.0M | -33.4% |